Fate Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $498k | 142k | 3.50 |
| 2024-06-30 | $618k | 189k | 3.28 |
| 2023-09-30 | $75k | 35k | 2.12 |
| 2023-06-30 | $202k | 35k | 5.70 |
| 2023-03-31 | $202k | 35k | 5.70 |
| 2022-12-31 | $789k | 78k | 10.09 |
| 2022-09-30 | $9.2M | 411k | 22.41 |
| 2022-06-30 | $13M | 514k | 24.78 |
| 2022-03-31 | $17M | 444k | 38.77 |
| 2021-12-31 | $25M | 427k | 58.51 |
| 2021-09-30 | $21M | 359k | 59.27 |
| 2021-06-30 | $30M | 344k | 86.79 |
| 2021-03-31 | $25M | 300k | 82.45 |
| 2020-12-31 | $23M | 568k | 39.97 |
| 2020-09-30 | $23M | 568k | 39.97 |
| 2020-06-30 | $19M | 557k | 34.31 |
| 2020-03-31 | $8.1M | 367k | 22.21 |
| 2019-12-31 | $11M | 552k | 19.57 |
| 2019-09-30 | $8.6M | 551k | 15.53 |
| 2019-06-30 | $11M | 539k | 20.30 |
| 2019-03-31 | $9.3M | 532k | 17.57 |
| 2018-12-31 | $6.6M | 514k | 12.83 |
| 2018-09-30 | $1.1M | 66k | 16.29 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas